Todd Bazemore, CHIEF OPERATING OFFICER at Kala Pharmaceuticals, Inc. (KALA), sold 2,911 shares at $5.77 ($17K) on 2021-06-28, disclosed to the SEC on 2021-06-29.
Scheduled sale ($17k) by CHIEF OPERATING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KALA | SELL | 2025-06-04 | $13K | — | Filing → |
| KALA | SELL | 2025-01-07 | $15K | — | Filing → |
| KALA | SELL | 2024-06-27 | $22K | — | Filing → |